Europe’s main pharmaceutical regulator recommended suspending the sale of hundreds of drug formulations that were approved for use based on “flawed” clinical studies conducted by an Indian research organization.
WSJ.com: About India, Wall Street Journal: Business: India
Sat, 01/24/2015 - 2:14am
Europe’s main pharmaceutical regulator recommended suspending the sale of hundreds of drug formulations that were approved for use based on “flawed” clinical studies conducted by an Indian research organization.